Capital Investment Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $25.2M | Sell |
27,421
-11
| -0% | -$11.2K | 0.37% | 71 |
|
|
2025
Q4 | $29.5M | Sell |
27,432
-308
| -1% | -$295K | 0.45% | 59 |
|
|
2025
Q3 | $21.2M | Sell |
27,740
-123
| -0.4% | -$91.5K | 0.35% | 71 |
|
|
2025
Q2 | $21.7M | Buy |
27,863
+267
| +1% | +$207K | 0.39% | 68 |
|
|
2025
Q1 | $22.8M | Buy |
27,596
+1,076
| +4% | +$895K | 0.45% | 63 |
|
|
2024
Q4 | $20.5M | Buy |
26,520
+1,292
| +5% | +$1.07M | 0.42% | 63 |
|
|
2024
Q3 | $22.4M | Sell |
25,228
-393
| -2% | -$353K | 0.46% | 61 |
|
|
2024
Q2 | $23.2M | Sell |
25,621
-433
| -2% | -$346K | 0.52% | 58 |
|
|
2024
Q1 | $20.3M | Sell |
26,054
-220
| -0.8% | -$157K | 0.47% | 62 |
|
|
2023
Q4 | $15.3M | Buy |
26,274
+27
| +0.1% | +$15.8K | 0.38% | 69 |
|
|
2023
Q3 | $14.1M | Buy |
+26,247
| New | +$13.5M | 0.39% | 68 |
|
|
2023
Q2 | – | Sell |
-27,547
| Closed | -$9.46M | – | 583 |
|
|
2023
Q1 | $9.46M | Sell |
27,547
-1,021
| -4% | -$344K | 0.28% | 84 |
|
|
2022
Q4 | $10.5M | Sell |
28,568
-892
| -3% | -$316K | 0.32% | 77 |
|
|
2022
Q3 | $9.53M | Sell |
29,460
-352
| -1% | -$112K | 0.33% | 77 |
|
|
2022
Q2 | $9.67M | Sell |
29,812
-208
| -0.7% | -$62.4K | 0.32% | 77 |
|
|
2022
Q1 | $8.6M | Buy |
30,020
+230
| +0.8% | +$59.2K | 0.26% | 85 |
|
|
2021
Q4 | $8.23M | Buy |
29,790
+131
| +0.4% | +$33.2K | 0.25% | 83 |
|
|
2021
Q3 | $6.85M | Sell |
29,659
-445
| -1% | -$110K | 0.23% | 89 |
|
|
2021
Q2 | $6.91M | Buy |
30,104
+983
| +3% | +$197K | 0.24% | 86 |
|
|
2021
Q1 | $5.44M | Sell |
29,121
-846
| -3% | -$165K | 0.2% | 94 |
|
|
2020
Q4 | $5.06M | Sell |
29,967
-551
| -2% | -$82.3K | 0.21% | 93 |
|
|
2020
Q3 | $4.52M | Sell |
30,518
-54
| -0.2% | -$8.36K | 0.22% | 94 |
|
|
2020
Q2 | $5.02M | Sell |
30,572
-318
| -1% | -$48.8K | 0.26% | 83 |
|
|
2020
Q1 | $4.29M | Sell |
30,890
-986
| -3% | -$135K | 0.27% | 80 |
|
|
2019
Q4 | $4.19M | Sell |
31,876
-82
| -0.3% | -$9.51K | 0.2% | 108 |
|
|
2019
Q3 | $3.57M | Sell |
31,958
-132
| -0.4% | -$14.7K | 0.19% | 112 |
|
|
2019
Q2 | $3.56M | Sell |
32,090
-841
| -3% | -$99K | 0.2% | 106 |
|
|
2019
Q1 | $4.27M | Sell |
32,931
-901
| -3% | -$110K | 0.25% | 95 |
|
|
2018
Q4 | $3.92M | Sell |
33,832
-1,724
| -5% | -$193K | 0.26% | 91 |
|
|
2018
Q3 | $3.82M | Buy |
35,556
+2,018
| +6% | +$202K | 0.23% | 92 |
|
|
2018
Q2 | $2.86M | Sell |
33,538
-1,589
| -5% | -$131K | 0.18% | 109 |
|
|
2018
Q1 | $2.72M | Buy |
35,127
+1,048
| +3% | +$84.4K | 0.18% | 115 |
|
|
2017
Q4 | $2.88M | Sell |
34,079
-338
| -1% | -$28.8K | 0.19% | 112 |
|
|
2017
Q3 | $2.94M | Sell |
34,417
-941
| -3% | -$77.2K | 0.2% | 108 |
|
|
2017
Q2 | $2.91M | Sell |
35,358
-133
| -0.4% | -$10.9K | 0.21% | 104 |
|
|
2017
Q1 | $2.98M | Buy |
35,491
+68
| +0.2% | +$5.45K | 0.23% | 99 |
|
|
2016
Q4 | $2.6M | Buy |
35,423
+25
| +0.1% | +$1.86K | 0.22% | 103 |
|
|
2016
Q3 | $2.84M | Sell |
35,398
-1,404
| -4% | -$112K | 0.25% | 94 |
|
|
2016
Q2 | $2.9M | Buy |
36,802
+181
| +0.5% | +$13.6K | 0.27% | 86 |
|
|
2016
Q1 | $2.64M | Sell |
36,621
-897
| -2% | -$67.9K | 0.26% | 84 |
|
|
2015
Q4 | $3.16M | Sell |
37,518
-1,370
| -4% | -$114K | 0.33% | 67 |
|
|
2015
Q3 | $3.25M | Sell |
38,888
-440
| -1% | -$37.1K | 0.37% | 61 |
|
|
2015
Q2 | $3.28M | Sell |
39,328
-2,411
| -6% | -$184K | 0.35% | 67 |
|
|
2015
Q1 | $3.03M | Buy |
41,739
+347
| +0.8% | +$24.7K | 0.32% | 76 |
|
|
2014
Q4 | $2.86M | Buy |
41,392
+679
| +2% | +$45.8K | 0.32% | 74 |
|
|
2014
Q3 | $2.64M | Buy |
40,713
+66
| +0.2% | +$4.18K | 0.3% | 80 |
|
|
2014
Q2 | $2.53M | Buy |
+40,647
| New | +$2.43M | 0.29% | 85 |
|
Other funds holding LLY
VCM
VPM
Capital Investment Advisors's LLY Position: Q1 2026 in Review
Capital Investment Advisors reduced its Eli Lilly (LLY) stake by 0.04% in Q1 2026, selling an estimated $11.2K and leaving 27,421 shares worth $25.2M. The position accounts for 0.37% of the portfolio, ranked #71.
Capital Investment Advisors first reported a position in LLY in Q2 2014 and has held it in 47 quarters since. The position peaked at $29.5M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Capital Investment Advisors held 27,421 shares of Eli Lilly worth $25.2M as of Q1 2026.
- Capital Investment Advisors sold 11 Eli Lilly shares in Q1 2026, an estimated $11.2K.
- Eli Lilly made up 0.37% of Capital Investment Advisors's portfolio in Q1 2026, its #71 holding.
- Capital Investment Advisors first reported a position in Eli Lilly in Q2 2014 and has held it in 47 quarters since.
- Capital Investment Advisors's Eli Lilly position peaked at $29.5M in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Capital Investment Advisors's 13F filing for Q1 2026, filed 16 Apr 2026.